Recalls & Warnings November 29, 2012 Sensa Settles Second False Advertising Lawsuit On November 27, 2012, Sensa Products LLC, maker of the Sensa Weight Loss System, announced it agreed to settle a false advertising lawsuit filed by the Nutritional Supplemental Task Force in California, without an admission of guilt
Multiple preclinical studies have identified that BPC-157 increases vascular endothelial growth factor (VEGF) protein and gene expression, a critical pathway in tissue repair and regeneration
Each mL of solution contains 1000 mcg of cyanocobalamin, used to treat vitamin B deficiencies, particularly in cases of malabsorption such as pernicious anemia
minimize exposure
Peptides differ widely in half-life, metabolism, and clearance making it essential to understand the mechanisms behind their duration of action